656 / 1498
Initial response predicts local progression
free survival
All
CR
PR
NR
# Patients
67
34
22
21
# Sites
90
37
30
23
Median Follow up (mos)
20.1
30.4
14.6
11.1
Median Time to local
progression (mos)
8.6
16.0
8.5
3.4
3 year LPFS
52.0%
80.1%
35.8%
16.7%